Log In
Print
BCIQ
Print
Print this Print this
 

OTX015, Y-803

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSynthetic small molecule inhibitor of BET bromodomain containing 2 (BRD2), BRD3 and BRD4
Molecular Target Bromodomain containing 2 (BRD2) ; Bromodomain containing 3 (BRD3)
Mechanism of ActionBromodomain containing 2 (BRD2) inhibitor; Bromodomain containing 3 (BRD3) inhibitor; Bromodomain containing 4 (BRD4) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$375.0M

$110.0M

$265.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today